These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

319 related items for PubMed ID: 29753928

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Salivary human beta-defensins affected by oral Candida status in Chinese HIV/AIDS patients undergoing ART.
    Liu Z, Yong X, Jiang L, Zhang L, Lin X, Liu W, Peng Y, Tao R.
    Oral Dis; 2018 Sep; 24(6):964-971. PubMed ID: 29498794
    [Abstract] [Full Text] [Related]

  • 4. Th1/Th2 cytokine expression in saliva of HIV-positive and HIV-negative individuals: a pilot study in HIV-positive individuals with oropharyngeal candidiasis.
    Leigh JE, Steele C, Wormley FL, Luo W, Clark RA, Gallaher W, Fidel PL.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec 01; 19(4):373-80. PubMed ID: 9833746
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Relationship of in vivo and ex vivo levels of TH1 and TH2 cytokines with viremia in HAART patients with and without opportunistic infections.
    Sindhu S, Toma E, Cordeiro P, Ahmad R, Morisset R, Menezes J.
    J Med Virol; 2006 Apr 01; 78(4):431-9. PubMed ID: 16482539
    [Abstract] [Full Text] [Related]

  • 7. Dynamic changes of Th1/Th2/Th17 cytokines and hBD-2/3 in erosive oral lichen planus patients saliva before and after prednisone acetate treatment.
    Jiang L, Huang Y, Fang M, Chen X, Feng D, Liu J, Jiang Q, Tao R.
    Heliyon; 2024 Jan 15; 10(1):e24043. PubMed ID: 38283247
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. IMMUNOLOGICAL PROFILES IN HIV POSITIVE PATIENTS FOLLOWING HAART INITIATION IN KIGALI, RWANDA.
    Twizerimana AP, Mwatha J, Musabyimana JP, Kayigi E, Harelimana Jde D, Karanja SM, Mutesa L.
    East Afr Med J; 2014 Aug 15; 91(8):261-6. PubMed ID: 26862650
    [Abstract] [Full Text] [Related]

  • 11. Dynamic analysis of oral Candida carriage, distribution, and antifungal susceptibility in HIV-infected patients during the first year of highly active antiretroviral therapy in Guangxi, China.
    Jiang L, Yong X, Li R, Peng Y, Liu W, Qin Q, Zhang L, Liu Z, Liang H, Tao R.
    J Oral Pathol Med; 2014 Oct 15; 43(9):696-703. PubMed ID: 24931443
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Immunity to Candida.
    Fidel PL.
    Oral Dis; 2002 Oct 15; 8 Suppl 2():69-75. PubMed ID: 12164664
    [Abstract] [Full Text] [Related]

  • 14. Demonstration of the Th1 to Th2 cytokine shift during the course of HIV-1 infection using cytoplasmic cytokine detection on single cell level by flow cytometry.
    Klein SA, Dobmeyer JM, Dobmeyer TS, Pape M, Ottmann OG, Helm EB, Hoelzer D, Rossol R.
    AIDS; 1997 Jul 15; 11(9):1111-8. PubMed ID: 9233457
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Short communication: decreasing soluble CD30 and increasing IFN-gamma plasma levels are indicators of effective highly active antiretroviral therapy.
    Sadeghi M, Süsal C, Daniel V, Naujokat C, Zimmermann R, Huth-Kühne A, Opelz G.
    AIDS Res Hum Retroviruses; 2007 Jul 15; 23(7):886-90. PubMed ID: 17678471
    [Abstract] [Full Text] [Related]

  • 17. The effect of a year of highly active antiretroviral therapy on immune reconstruction and cytokines in HIV/AIDS patients.
    Yao Y, Luo Y, He Y, Zheng Y, Zhang Q, Zhou H, Zeng S, Chen Z, He B, He M.
    AIDS Res Hum Retroviruses; 2013 Apr 15; 29(4):691-7. PubMed ID: 23151174
    [Abstract] [Full Text] [Related]

  • 18. Oral Candida colonization and its relation with predisposing factors in HIV-infected children and their uninfected siblings in Brazil: the era of highly active antiretroviral therapy.
    Cerqueira DF, Portela MB, Pomarico L, de Araújo Soares RM, de Souza IP, Castro GF.
    J Oral Pathol Med; 2010 Feb 15; 39(2):188-94. PubMed ID: 20040023
    [Abstract] [Full Text] [Related]

  • 19. Expression of a novel cytokine, IL-4delta2, in HIV and HIV-tuberculosis co-infection.
    Dheda K, Chang JS, Breen RA, Haddock JA, Lipman MC, Kim LU, Huggett JF, Johnson MA, Rook GA, Zumla A.
    AIDS; 2005 Oct 14; 19(15):1601-6. PubMed ID: 16184029
    [Abstract] [Full Text] [Related]

  • 20. Dynamic study of oral Candida infection and immune status in HIV infected patients during HAART.
    Du X, Xiong H, Yang Y, Yan J, Zhu S, Chen F.
    Arch Oral Biol; 2020 Jul 14; 115():104741. PubMed ID: 32417705
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.